Jessica Oien - 19 Aug 2024 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)

Role
Chief Legal Officer and Corporate Secretary
Signature
/s/ Jessica Oien
Issuer symbol
BOLD
Transactions as of
19 Aug 2024
Net transactions value
$0
Form type
4
Filing time
20 Aug 2024, 19:11:00 UTC
Previous filing
29 Mar 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLD Stock Option Disposed to Issuer -32,051 -100% 0 19 Aug 2024 Common Stock 32,051 $4.10 Direct F1, F2
transaction BOLD Stock Option Disposed to Issuer -29,148 -100% 0 19 Aug 2024 Common Stock 29,148 $4.10 Direct F2, F3
transaction BOLD Stock Option Disposed to Issuer -10,200 -100% 0 19 Aug 2024 Common Stock 10,200 $4.10 Direct F2, F4
transaction BOLD Stock Option Disposed to Issuer -42,051 -100% 0 19 Aug 2024 Common Stock 42,051 $4.10 Direct F2, F5
transaction BOLD Stock Option Disposed to Issuer -35,897 -100% 0 19 Aug 2024 Common Stock 35,897 $4.49 Direct F2, F6
transaction BOLD Stock Option Disposed to Issuer -26,090 -100% 0 19 Aug 2024 Common Stock 26,090 $8.19 Direct F2, F7
transaction BOLD Stock Option Disposed to Issuer -16,234 -100% 0 19 Aug 2024 Common Stock 16,234 $16.00 Direct F2, F8
transaction BOLD Stock Option Award +32,051 32,051 19 Aug 2024 Common Stock 32,051 $3.56 Direct F1, F2, F9
transaction BOLD Stock Option Award +29,148 29,148 19 Aug 2024 Common Stock 29,148 $3.56 Direct F2, F3, F9
transaction BOLD Stock Option Award +10,200 10,200 19 Aug 2024 Common Stock 10,200 $3.56 Direct F2, F4, F9
transaction BOLD Stock Option Award +42,051 42,051 19 Aug 2024 Common Stock 42,051 $3.56 Direct F2, F5, F9
transaction BOLD Stock Option Award +35,897 35,897 19 Aug 2024 Common Stock 35,897 $3.56 Direct F2, F6, F9
transaction BOLD Stock Option Award +26,090 26,090 19 Aug 2024 Common Stock 26,090 $3.56 Direct F2, F7, F9
transaction BOLD Stock Option Award +16,234 16,234 19 Aug 2024 Common Stock 16,234 $3.56 Direct F2, F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 25% of the underlying shares on August 30, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.
F2 On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.
F3 The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.
F4 The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2023.
F5 The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.
F6 The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.
F7 The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.
F8 The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.
F9 The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

Remarks:

Chief Legal Officer and Corporate Secretary